Title: Pharmaceutical Contract Services Market
1Pharmaceutical Contract Services Market
2A. Contract research organizations
- Offer pharmaceutical companies a range of
services covering all phases of drug development - Increasing emphasis on informatics services to
complement other activities - Enable big pharma firms to staff for valleys
rather than peaks of research cycle - Facilitate worldwide testing of new products
- Dependence on pharmaceutical companies budgets
creates high volatility in results - CROs involvement in genetic research will have a
long-term payback
3Company Profiles
- Quintiles Transnational Corp. largest CRO, with
revenues of 2.15 bil. Provides integrated
product and commercial development services to
the pharma, biotech and medical industries - Covance Offers broad range of outsourced
development services growth through
acquisitions diversifying into biotechnology - Parexel International Corp. Clinical research,
consulting, medical marketing and informatics,
growth through acquisitions - continued next page
4Company Profiles (contd)
- Pharmaceutical Product Development, Inc.
includes PPD Discovery (genomics technology), PPD
Development (analytical lab and Phase I-IV
clinical development services, and PPD Virtual
(consulting) - Inveresk Research Group pre-clinical and
pharmacology evaluation services acquired Clin
Trials Research - Kendle International clinical research and
drug development services acquisitive - ICON plc clinical research for pharma and
biotech industries
5- Contract Research Organizations (CROs) Summary
- ( in millions)
¹ Represents sum of market value of common stock
and equivalents ² Prices as of 5/01/05
6B. Manufacturing services organizations
- U.S. market for outsourced pharmaceutical
manufacturing is growing - Integration of pharmaceutical research,
manufacturing and packaging services - Chemical Industry still has less outsourcing than
other industries
7- Benefits of outsourcing can be measured by
comparing new paradigm with former pharmaceutical
business model
New Paradigm
Old Paradigm
Entire Supply Chain
Focus
Factories
Discount Cash Flow (DCF)
COGS
Costs
Recycle Capacity
Add Capacity
New Products
Outsource
Add Capacity
Existing Products
Under-utilized Assets
Avoid Capital Investment Reinvest cash in RD and
in Marketing
Results
Source Patheon Co. website
8Company Profiles
- Lonza Group AG supplier of active chemical
ingredients, intermediates and biotechnology
solutions to the pharma and agrochemical
industries 1.3 billion in revenues - CCL Industries Canadian co. providing
outsourcing in personal care, OTC pharma and oral
care products - Cambrex Corp. Life sciences company providing
pharmaceutical ingredients, intermediates and
services to drug companies - Patheon Co. Vertically integrated approach to
pharmaceutical development with manufacturing
expertise in both prescription and OTC products - continued next page..
9Company Profiles (contd)
- Catalytica acquired by DSM in Dec. 2000.
Pharmaceutical and fine chemical contract
manufacturer - ChiRex aqcquired by Rhodia in Sept. 2000.
Contract research and contract manufacturing of
active pharmaceutical ingredients - Draxis Pharma unit of Draxis Health inc.
Contract manufacturer with ability to produce a
variety of dosage forms also packaging
capability - DPT Laboratories acquired West Pharmaceutical
Services contract manufacturing unit in November
2001.
10- Manufacturing Services Companies Summary
- ( in millions)
¹ Represents sum of market value of common stock
and equivalents ² Prices as of 5/01/05
11C. Information Technology Companies
- Sector Fundamentals
- Provide the following services
- lt Health portals (health information sites)
- lt Connectivity and communications services
- lt E-commerce, including on-line health insurance
and drug prescriptions - Rising costs compel industry participants to
examine use of technology - Consumers are becoming more active in their
health care management, as managed care is
redefining the doctor-patient relationship
12C. Information Technology Companies (contd)
- Health care had under-invested in information
technology relative to other industries - As the health care delivery model changes,
participants need additional information to
measure outcomes
13Company Profiles
- IMS Health Inc. Split off from Cognizant in
Jan. 1998. Provides market information and
decision support services to the healthcare
sector - Web MD Corp. Leverages Internet to provide
services that connect participants in health care
sector and automate workflow - Cerner Corp. Information management systems,
primarily sold to hospitals - IDX Systems Corp. Information systems and
medical transcription services - continued next page ..
14Company Profiles (contd)
- NDC Health Corp. Point-of-service systems, high
volume, network-based information solutions and
information management systems - Eclipsys Corp. Healthcare information systems
- The TriZetto Group Internet hosting and
software consulting services - Allscripts Inc. Point-of-care medication
management, distribution and software
15- Information Technology Companies Summary
- ( in millions)
¹ Represents sum of market value of common stock
and equivalents ² Prices as of 5/01/05
16D. Developing Trends
- Pharmaceutical and consumer product manufacturers
expected to increase their contract activities to
reduce costs and improve speed to market - Complexity of FDA approval process enhances
values of already approved proprietary
methodologies and heightens attractiveness of
contract services - European manufacturers of pharmaceutical and fine
chemicals such as DSM and Lonza may be contract
service providers to establish a presence in the
US market - Competitive environment in outsourcing has
intensified, due to existing production
overcapacities at the pharma companies coupled
with the declining number of approvals for new
products - Future consolidation likely through mergers and
acquisitions